How to Combine the Two Landmark Treatment Methods—Allogeneic Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Together to Cure High-Risk B Cell Acute Lymphoblastic Leukemia?

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) has made tremendous progress in the last few decades and is increasingly being used worldwide. The success of haploidentical HSCT has made it possible to have “a donor for everyone”. Patients who received transplantation in remission may...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Mingming, Huang, He
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7770154/
https://www.ncbi.nlm.nih.gov/pubmed/33384696
http://dx.doi.org/10.3389/fimmu.2020.611710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7770154/
https://www.ncbi.nlm.nih.gov/pubmed/33384696
http://dx.doi.org/10.3389/fimmu.2020.611710

Ejemplares similares